Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Aleglitazar

🥰Excellent
Catalog No. T14176Cas No. 475479-34-6
Alias RO0728804, R1439

Aleglitazar (R1439) (R1439) is a potent dual PPARα/γ agonist, with IC50s of 38 nM and 19 nM for human PPARa and PPARγ, respectively. Aleglitazar can be used for the research of type II diabetes.

Aleglitazar

Aleglitazar

🥰Excellent
Purity: 99.42%
Catalog No. T14176Alias RO0728804, R1439Cas No. 475479-34-6
Aleglitazar (R1439) (R1439) is a potent dual PPARα/γ agonist, with IC50s of 38 nM and 19 nM for human PPARa and PPARγ, respectively. Aleglitazar can be used for the research of type II diabetes.
Pack SizePriceAvailabilityQuantity
1 mg$258In Stock
5 mg$592In Stock
10 mg$798In Stock
25 mg$1,220In Stock
50 mg$1,650In Stock
100 mg$2,220In Stock
1 mL x 10 mM (in DMSO)$598In Stock
Bulk & Custom
Add to Cart
Questions
View More
Select Batch
Purity:99.42%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Aleglitazar (R1439) (R1439) is a potent dual PPARα/γ agonist, with IC50s of 38 nM and 19 nM for human PPARa and PPARγ, respectively. Aleglitazar can be used for the research of type II diabetes.
Targets&IC50
PPARγ:19 nM, PPARα:38 nM
In vitro
Aleglitazar exhibits species selectivity for PPARα, with EC50 values of 50 nM, 2.26 μM, and 2.34 μM for human, rat, and mouse PPARα, respectively[1]. At concentrations of 0.01-40 μM (12-48 hours), aleglitazar does not significantly increase lactate dehydrogenase (LDH) release at 0.1-20 μM but shows significant increases at 30 μM and 40 μM[2]. Additionally, aleglitazar (0.01-20 μM; 48 hours) decreases hyperglycemia (HG, glucose 25 mM)-induced apoptosis, caspase-3 activity, and cytochrome-C release, while improving cell viability in hyperglycemic conditions[2].
In vivo
Aleglitazar (0.3-3.0 mg/kg; i.p.; daily; for 7 days) exerts beneficial effects on structural and functional outcomes of mild brain ischemia, reduces key aspects of microglia activation including NO production, release of proinflammatory cytokines, migration, and phagocytosis, and attenuates inflammatory responses in the post-ischemic brain[3].
AliasRO0728804, R1439
Chemical Properties
Molecular Weight437.51
FormulaC24H23NO5S
Cas No.475479-34-6
SmilesC([C@@H](C(O)=O)OC)C1=C2C(=C(OCCC=3N=C(OC3C)C4=CC=CC=C4)C=C1)C=CS2
Relative Density.1.29
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 45 mg/mL (102.9 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.2857 mL11.4283 mL22.8566 mL114.2831 mL
5 mM0.4571 mL2.2857 mL4.5713 mL22.8566 mL
10 mM0.2286 mL1.1428 mL2.2857 mL11.4283 mL
20 mM0.1143 mL0.5714 mL1.1428 mL5.7142 mL
50 mM0.0457 mL0.2286 mL0.4571 mL2.2857 mL
100 mM0.0229 mL0.1143 mL0.2286 mL1.1428 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Aleglitazar | purchase Aleglitazar | Aleglitazar cost | order Aleglitazar | Aleglitazar chemical structure | Aleglitazar in vivo | Aleglitazar in vitro | Aleglitazar formula | Aleglitazar molecular weight